CBD & CBG UNLOCKED
We bring you the first dermo-genomics
study on CBD & CBG
Human genes (mRNA)
Despite CBD’s success, its dermo-cosmetic efficacy had yet to be demonstrated and its modes of action identified. The Spectrums Europe study on Optima® CBD provides a complete mapping of its molecular signature in the skin.
CBG, cannabigerol, is the precursor molecule of all phytocannabinoids found in hemp. Very little was known about it. The study on Optima® CBG has unlocked its potential as a powerful anti-aging molecule with novel mode of actions.
We know that skin aging or skin disorders are always the result of multiple causes and translate into complex interactions within the skin. Bringing proof of the systemic action of Optima® CBD and CBG while at the same time revealing original pathways (EVPLL, NMRAL2P, SP6, ...), Spectrums dermo-genomics study lays out the foundations of new skin care strategies.